These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 4748872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
    Douglass HO, Lavin PT, Moertel CG.
    Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
    [Abstract] [Full Text] [Related]

  • 6. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The nitrosoureas--thoughts for the future.
    Carter SK, Wasserman TH.
    Cancer Treat Rep; 1976 Jun; 60(6):807-11. PubMed ID: 954014
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ, Kaufman JH, Douglass HO, Mittelman A.
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract] [Full Text] [Related]

  • 12. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA, Richardson RL, Shulman SF, Oldham RK.
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ, Rapp E.
    Cancer Chemother Rep; 1974 Sep; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract] [Full Text] [Related]

  • 14. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH, Vaitkevicius VK, Gehan E.
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [Abstract] [Full Text] [Related]

  • 15. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
    Abdallah AM, Soukop M, Bell G, Calman KC.
    Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
    [No Abstract] [Full Text] [Related]

  • 16. The phase II study: some reflections, particularly concerning disseminated breast cancer.
    Ahmann DL.
    Cancer Chemother Rep 3; 1972 May; 3(1):29-32. PubMed ID: 5049705
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
    Earhart RH, Moertel C, Hahn RG, Woodhouse CL, Ramirez G, Engstrom PF.
    Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
    [Abstract] [Full Text] [Related]

  • 20. Nitrosoureas in central nervous system tumors.
    Walker MD.
    Cancer Chemother Rep 3; 1973 May; 4(3):21-6. PubMed ID: 4584033
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.